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Abstract
 
Whereas ligation of CD28 is known to provide a critical costimulatory signal for activation of
CD4 T cells, the requirement for CD28 as a costimulatory signal during activation of CD8
cells is less well defined. Even less is known about the involvement of CD28 signals during pe-
ripheral tolerance induction in CD8 T cells. In this study, comparison of T cell responses from
CD28-deficient and CD28 wild-type H-Y–specific T cell receptor transgenic mice reveals that
CD8 cells can proliferate, secrete cytokines, and generate cytotoxic T lymphocytes efficiently
in the absence of CD28 costimulation in vitro. Surprisingly, using pregnancy as a model to
study the H-Y–specific response of maternal T cells in the presence or absence of CD28 co-
stimulation in vivo, it was found that peripheral tolerance does not occur in CD28KO preg-
nants in contrast to the partial clonal deletion and hyporesponsiveness of remaining T cells ob-
served in CD28WT pregnants. These data demonstrate for the first time that CD28 is critical
for tolerance induction of CD8 T cells, contrasting markedly with CD28 independence of in
vitro activation, and suggest that the role of CD28/B7 interactions in peripheral tolerance of
CD8 T cells may differ significantly from that of CD4 T cells.
Key words: pregnancy • clonal deletion • clonal anergy • B7 costimulatory molecules • 
cytotoxic T lymphocytes
 
Introduction
 
The antigen specificity of T cells is determined by the
 
TCR
 
  
 
 heterodimer. However, the ability of a T cell to
be activated by TCR-mediated antigen recognition is regu-
lated by additional signals such as those provided by cell
surface costimulatory molecules. A critically important co-
stimulatory pathway that functions in control of CD4 T cell
activation is the highly studied CD28/CTLA-4/B7 path-
way. T cells express cell surface CD28 that interacts with its
ligands B7.1 or B7.2 expressed primarily on APCs such as
macrophages, B cells, and dendritic cells (1). In vitro, TCR
activation (signal one) in the absence of CD28 (signal two)
has been shown to induce anergy, a state of unresponsive-
ness to subsequent encounters with antigen (2, 3), whereas
TCR signaling in conjunction with costimulatory CD28
augments T cell activation by up-regulating mechanisms
that enhance survival (bcl-2) and proliferation (IL-2 pro-
duction; references 4–6). T cell responses are also modu-
 
lated by a second B7 receptor, CTL antigen 4 (CTLA-4),
 
*
 
which delivers negative signals that down-regulate T cell
activation (7, 8).
The role of the CD28/CTLA-4/B7 costimulatory path-
way in CD4 T cell activation has also been analyzed in in
vivo models. CD28KO mice are deficient in T cell–depen-
dent antibody responses and in other responses dependent
on CD4 Th activity (9). In contrast, CTLA-4 KO mice
suffer from a lethal, massive lymphoproliferation of CD4 T
cells driven by antigen, implicating CTLA-4 as critical for
down-regulation of CD4 T cell activation (10, 11). A series
of studies using adoptive transfer of OVA-specific class II–
restricted TCR transgenic T cells has dissected the roles of
CD28/CTLA-4/B7 pathways in immunity and tolerance
in vivo (12–17). Inhibition of both CD28 and CTLA-4
signaling by administration of CTLA-4-Ig in vivo pre-
vented priming of OVA-specific CD4 T cells. However,
these T cells maintained their naive phenotype and were
capable of subsequent response to antigen challenge, sug-
gesting that TCR signaling alone could not drive T cells to
become either activated or anergized (14). If only the B7/
CTLA-4 pathway was inhibited, either with anti–CTLA-4
antibodies (14) or in CTLA-4–deficient mice (17), CD4 T
cells were not only primed to antigen delivered in an immu-
nogenic manner, but also to antigen presented in a tolero-
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Abbreviations used in this paper:
 
 CTLA, CTL antigen; TCM, tissue cul-
ture medium.T
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genic manner, compatible with a requirement for CTLA-4
in the induction of anergy in vivo. These data imply that
signal 2 provided through CD28 drives full activation of
CD4 T cells, whereas signaling through CTLA-4 results
in a negative signal that can induce long-term antigen-
specific tolerance.
Although the importance of CD28 signaling in CD4 T
cell systems is well established both in vivo and in vitro, the
role of CD28 in the activation of CD8 T cells is less clear.
A number of in vitro systems have demonstrated CD28 in-
dependence of CD8 T cell activation (18–20) whereas oth-
ers have shown that CD28 is required for optimal activa-
tion of CD8 cells (21–23). In vivo, it was found in one
study that induction of LCMV-specific CTL activity was
not detectably different in CD28-deficient and CD28
wild-type mice (9). Other groups have explored the role
of CD28/B7 interactions in CD4-independent CD8 re-
sponses in vivo and have shown that while antigen-specific
T cell expansion in CD28-deficient mice is indeed dimin-
ished, these cells are still capable of developing effector
function and memory responses (24, 25).
The role of CD28 costimulation in induction of periph-
eral tolerance in CD8 T cells has not previously been as-
sessed. To address this question, female CD28-deficient
H-Y–specific TCR transgenic mice were compared with
their CD28WT counterparts for the induction of tolerance
to the H-Y antigen expressed by male fetuses during preg-
nancy. Surprisingly, while CD28 is dispensable for in vitro
activation of CD28-deficient H-Y–specific T cells, it was
found that CD28 is required for the induction of decreased
antigen-specific proliferation and CTL generation as well as
for clonal deletion of peripheral CD8 T cells.
 
Materials and Methods
 
Mice.
 
H-Y–specific TCR transgenic RAG-2 knockout
(CD28WT H-Y) mice were generated as described previously
(26) and maintained in our breeding facility at Bioqual Inc.
(Rockville, MD). CD28WT H-Y mice were bred with mice de-
ficient in CD28 (CD28KO; The Jackson Laboratory) to establish
TCR transgenic RAG-2–deficient CD28-deficient (CD28KO
H-Y) lines. H-Y mice were also bred to mice deficient for both
B7–1 and B7–2 (B7DKO; gift of Arlene Sharpe, Harvard Uni-
versity, Cambridge, MA) to establish TCR transgenic RAG-2–
deficient B7–1 and B7–2–deficient (B7DKO H-Y) lines.
C57BL/6 mice were obtained from National Cancer Institute,
Frederick Cancer Research Facility (Frederick, MD).
Timed pregnant females were generated by mating females
with syngeneic males for 18 h. The day the pair was separated was
counted as day 0 (d0) of gestation. Pregnant females were killed at
day 18 of gestation (d18), and spleen cell suspensions were pre-
pared. Sex of the fetuses from each pregnancy was determined
microscopically and the number of males/litter noted.
 
Cell Culture.
 
Single cell suspensions were prepared and main-
tained in complete tissue culture medium (TCM) consisting of
10% FBS, 2 mM 
 
l
 
-glutamine, 100 U/ml penicillin, 100 
 
 
 
g strep-
tomycin, 20 mM HEPES, 100 
 
 
 
M nonessential amino acids, 1
mM sodium pyruvate, and 25 
 
 
 
M 2-ME in RPMI 1640 (Bio-
whittaker). Cell cultures were maintained at 37
 
 
 
C in 5% CO
 
2
 
.
 
Cellular Proliferation Assay.
 
Spleen cells were washed exten-
sively in 1
 
 
 
 PBS to remove residual protein, then 10
 
7
 
 spleen
cells/ml were incubated in 1 
 
 
 
M CFSE (Molecular Probes) for 8
min at room temperature as described previously (27). The label-
ing reaction was quenched with an equal volume of FBS, the
cells centrifuged, then washed three times in TCM. CFSE-
labeled cells were diluted in TCM and were cultured at 4 
 
 
 
 10
 
5
 
in 96-well U-bottom plates for 72 h in the absence or presence of
titrated H-Y peptide (KCSRNRQYL; reference 28). Alterna-
tively, CFSE-labeled cells were cultured with 4 
 
 
 
 10
 
5
 
 irradiated
C57BL/6 male spleen cells (500R) as a source of H-Y-expressing
APCs. Cultures were harvested at 72 h, stained with biotinylated
anti-T3.70 (for the detection of the clonotypic H-Y–specific T
cells [29]) for 30 min at 4
 
 
 
C, washed 3
 
  
 
in FACS
 
®
 
 buffer (0.2%
BSA, 0.01% sodium azide in HBSS without phenol red), then in-
cubated with avidin-CyChrome for 10 min (BD Biosciences)
followed by extensive washing in FACS
 
®
 
 buffer. Immediately
before analysis, cells were resuspended in Annexin-binding buffer
(BD Biosciences) and labeled with Annexin-V-PE per manufac-
turer’s instructions (BD Biosciences) with the exception that An-
nexin V was diluted 1:5 rather than used neat. Cells were ana-
lyzed on a FACScan™ cytometer (BD Biosciences). 10,000
events in a live gate were acquired although all ungated events
were saved for later analysis.
 
Intracellular Cytokine Assay.
 
Spleen cells were labeled with
CFSE and cultured with 500R-irradiated C57BL/6 male APCs,
1,000 nM H-Y peptide, or 1 nM H-Y peptide for 72 h. At 72 h,
either 200 ng/ml PMA plus 750 ng/ml ionomycin or 1,000 nM
peptide were added with GolgiStop (as per manufacturer’s recom-
mendation; BD Biosciences) to the cultures for an additional 5 h
at 37
 
 
 
C in 5% CO
 
2
 
. Cultures were then harvested and labeled
with T3.70-biotin followed by avidin-CyChrome as described
above. Detection of intracellular cytokines was performed as de-
scribed by manufacturer’s instructions (BD Biosciences). Briefly,
cells were fixed in Cytofix/Cytoperm solution for 20 min at
room temperature, washed in PermWash buffer, then incubated
with PE-labeled antibodies, anti–mouse IFN-
 
 
 
, or the recom-
mended isotype control for 30 min, followed by extensive washes
in PermWash buffer before analysis on a FACScan™. 10,000
events gated on T3.70-positive cells were collected. The percent-
age of IFN-
 
 
 
–expressing cells was calculated by subtracting the
background staining observed with the isotype control from the
percentage observed with the IFN-
 
 
 
–specific antibody.
 
Flow Cytometry–based CTL Assay.
 
Spleen cell suspensions
were prepared and labeled with CFSE as described above. 4 
 
 
 
10
 
6
 
 CFSE-labeled spleen cells/ml were cultured for 72 h with
H-Y peptide at 37
 
 
 
C in 5% CO
 
2
 
. At the end of cultures, cells were
harvested and passed over Lymphocyte Separation Medium (ICN
Biochemicals) to eliminate dead cells. Cells were then washed,
resuspended in TCM, and counted. Flow cytometric analysis of
this population revealed that 
 
 
 
90% express the clonotypic TCR.
These effector populations were then cultured with EL-4 targets
in the absence or presence of 1 
 
 
 
M H-Y peptide for 4 h at vari-
ous effector to target ratios. In some experiments, an irrelevant
peptide (pigeon cytochrome C 88–104 (KAERADLIAY-
LKQATAK; reference 30) was also used and showed no differ-
ence from EL-4 cells alone. At the end of 4 h, cultures were har-
vested, centrifuged, and resuspended in Annexin-binding buffer
(BD Biosciences). Annexin-V-PE and propidium iodide were
added per manufacturer’s instructions (BD Biosciences). Analysis
of target cell death was performed by gating on EL-4 cells
(FSC
 
hi
 
CFSE
 
neg
 
) and assessing expression of Annexin V. Specific
death was calculated by subtracting the percentage of AnnexinT
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V–positive targets in culture with effectors but no peptide, from
the percentage of Annexin V targets in cultures in which H-Y
peptide was present.
 
Results
 
CD28 Is Not Required for Proliferation, IFN-
 
 
 
 Production,
or CTL Induction by H-Y–specific T Cells from TCR Trans-
genic Mice.
 
To assess the requirement for CD28 in class
I–restricted T cell responses to antigen, we evaluated in vitro
the responsiveness of TCR transgenic H-Y-specific T cells
that either do or do not express CD28 (CD28WT H-Y or
CD28KO H-Y). In all cases the TCR transgenic mice used
in experiments are RAG-2 KO. Responsiveness was as-
sessed by three criteria: proliferative responses, cytokine
production, and CTL activity. Spleen cells from CD28WT
or CD28KO H-Y females were labeled with CFSE and the
proliferative responses to peptide or male APC stimulation
evaluated by CFSE dye dilution. Fig. 1 a illustrates prolifer-
ative responses of clonotype T3.70
 
 
 
 T cells from H-Y
CD28WT and CD28KO females in response to titrated
doses of peptide. T cells from KO mice responded to both
high (1,000 nM) and low dose (0.1 nM) peptide as well as
T cells from WT mice. There was no proliferation to a
nonspecific peptide (pCytC 88–104, unpublished data)
confirming specificity of the proliferative response. Cul-
tures from CD28KO H-Y mice demonstrated expansion of
clonotypic T cells that was comparable to that from
CD28WT cultures at the end of 72 h, indicating that
CD28KO cells both proliferate and survive in response
to antigen (unpublished data). Equivalent responses by
CD28KO and CD28WT T cells were also observed when
T cells were stimulated with male APCs, representing en-
counter with “physiological” levels of the H-Y peptide.
(Fig. 1 b).
To further evaluate a role for CD28 costimulation in the
generation of effector function in vitro, cytokine produc-
tion and CTL activity were evaluated. The IFN-
 
 
 
 response
of CD28KO H-Y T cells was comparable to that of
CD28WT H-Y T cells when activated with 1000nM pep-
tide (Fig. 1 c) or with 1 nM peptide (see Fig. 3 c). H-Y–
specific T cells from CD28WT or CD28KO mice were
also assayed for H-Y–specific cytotoxic activity after 72 h
of in vitro stimulation with 1 
 
 
 
M H-Y peptide and re-
vealed undiminished CTL generation in the absence of
CD28 (Fig. 1 d). Thus, CD28-deficient T cells can prolif-
erate efficiently in vitro to even low doses of antigen, and
are not inhibited in their ability to generate CTL and IFN-
 
 
 
responses when compared with CD28-expressing T cells.
 
In Vivo Encounter of Antigen during Pregnancy Results in a
Partial Clonal Deletion of CD28WT but Not CD28KO H-Y–
specific T Cells.
 
To determine the role that CD28 may
play in an in vivo response to physiological “self” antigen,
we next compared the ability of pregnancy to induce clonal
deletion and altered T cell responsiveness in CD28WT and
CD28KO mice. We have previously described that the
number of H-Y–specific T cells in the spleen and lymph
nodes of female TCR transgenic mice decreased in an anti-
 
gen-specific manner during pregnancy (26). In the present
study, when compared with nonpregnant controls, the
number of clonotypic T cells decreased by 
 
 
 
50% (4.2 vs.
2.0 
 
 
 
 10
 
6
 
, P 
 
  
 
0.05) in the spleens of CD28WT females at
day 18 of pregnancy (d18) when male fetuses were present,
but not when litters consisted only of female fetuses (5.3 
 
 
 
10
 
6
 
; Fig. 2 a). Recovery of non–T cells from d18 pregnant
females was not significantly different from that observed
Figure 1. CD28 is not required for H-Y–specific T cell proliferation,
IFN- , or CTL function. 4   105 CFSE-labeled CD28WT or CD28KO
H-Y spleen cells were cultured with (a) various concentrations of H-Y
peptide or (b) 4   105 C57BL/6 male spleen cells for 72 h, harvested, and
analyzed for dye dilution after gating on T3.70  (anti-H-Y specific)
Annexin V  cells. Results represent pooled data from multiple experi-
ments (CD28WT, n   28; CD28KO, n   10). Cultures without antigen
generally had  5% of cells with  3 divisions. (c) Absence of CD28 does
not alter IFN-  production. 4   105 spleen cells from CD28WT or
CD28KO H-Y mice were cultured in the presence of 1,000 nM peptide
for 72 h, then harvested and cultured for an additional 6 h in the presence
of GolgiStop, 200 ng/ml PMA, and 750 ng/ml ionomycin. Similar results
were obtained stimulating with peptide instead of PMA and ionomycin.
Clonotypic T cells were analyzed for intracellular expression of IFN- .
Results represent pooled data from multiple experiments. (CD28WT,
n   8; CD28KO, n   8). (d) Absence of CD28 does not inhibit the gen-
eration of CTL function in vitro. 4   106 CFSE-labeled spleen cells from
CD28WT or CD28KO H-Y mice were cultured with 1  M peptide for
72 h, harvested, and cultured with EL-4 cells in the absence or presence
of peptide for 4 h, and EL-4 cells then analyzed for expression of Annexin
V as an indicator of death. % specific death   % Annexin V–positive tar-
gets in the presence of peptide minus % Annexin V–positive targets with-
out peptide. Results represent pooled data from multiple experiments.
(CD28WT, n   9; CD28KO, n   6.)T
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from nonpregnant females (19.1 vs. 17.4 
 
 
 
 10
 
6
 
) or preg-
nant females carrying litters consisting only of females
(20.2 
 
 
 
 10
 
6
 
). In contrast, there was no significant decrease
in clonotype-positive T cells in the spleens of pregnant
CD28KO mice (6.8 vs. 6.7 
 
 
 
 10
 
6
 
; Fig. 2 a), indicating that
clonal elimination is CD28-dependent. Splenic size was
comparable between nonpregnants from the WT and KO
strain (23.3 vs. 27.2 
 
 
 
 10
 
6
 
).
To further characterize the phenotype of H-Y–specific
T cells from pregnant CD28WT and CD28KO H-Y mice,
we analyzed levels of CD62L, an indicator of previous anti-
gen encounter. Fig. 2 b reveals that the clonotypic T cells
remaining in the d18 pregnant CD28WT females exhibit a
significant increase in the percentage of T cells that are
CD62L
 
lo
 
 compared with T cells recovered from CD28WT
females whose litters consisted only of females (35.9 
 
 
 
0.8% vs. 12.4 
 
 
 
 1.6%, P 
 
  
 
0.01) or nonpregnant females
(18.3 
 
 
 
 2.8%; Fig. 2 b). In contrast, there was no increase
in CD62L
 
lo
 
 cells from pregnant CD28KO H-Y as com-
pared with CD28KO H-Y nonpregnants (Fig. 2 b). There
were no alterations in either TCR or CD8 levels in
CD28KO T cells compared with CD28WT cells from ei-
ther nonpregnant or pregnant mice (unpublished data).
 
In Vivo Encounter of Antigen during Pregnancy Results in
Hyporesponsiveness in Remaining H-Y–specific T Cells in
CD28WT but Not in CD28KO Mice.
 
We next addressed
the ability of pregnancy and H-Y exposure to induce anti-
gen-specific unresponsiveness in CD28KO mice. CFSE-
labeled spleen cells from CD28WT or CD28KO H-Y mice
were stimulated in vitro with peptide and assessed for pro-
liferation of clonotypic Annexin V–negative cells. There
was a significant decrease in the ability of the remaining T
cells from d18 pregnant CD28WT H-Y females to prolifer-
ate in response to H-Y peptide when compared with non-
pregnant controls or females pregnant with litters of only
female fetuses (Fig. 3 a). When stimulated with 0.1 nM
peptide, only 13 
 
 
 
 5.3% of T3.70 cells from CD28WT
H-Y d18 pregnant females underwent 3 or more divisions,
whereas 37 
 
 
 
5.4% and 63 
 
 
 
14% of T3.70 cells divided
three or more times from CD28WT H-Y nonpregnant fe-
 
males or CD28WT H-Y pregnancies with all-female litters,
respectively (Fig. 3, a and b; P 
 
  
 
0.05). In contrast, clono-
typic cells from CD28KO H-Y pregnant mice proliferated
comparably to T cells from CD28KO H-Y nonpregnants
(60 
 
 
 
 12% vs. 69 
 
 
 
 12%; Fig. 3 b). Similar results were ob-
tained with male APCs as a source of antigen (Fig. 3 b).
Cells from CD28WT H-Y d18 pregnants could be driven
to divide to a degree similar to nonpregnant controls when
challenged with a potent TCR stimulus such as high dose
(1,000 nM) peptide or anti-TCR antibodies (unpublished
data, and reference 26). These results suggest that when
class I restricted, H-Y–specific T cells encounter fetal H-Y
antigen in vivo, both clonal deletion and the induction of
hyporesponsiveness contribute to peripheral tolerance, and
that both mechanisms are CD28 dependent.
To further address the phenotype and functionality of T
cells from d18 pregnant CD28KO and CD28WT mice, we
assessed two parameters of functional activation: cytokine
production and CTL activity. Splenic T cells from non-
pregnant or pregnant CD28WT H-Y and CD28KO H-Y
females were compared for the ability to produce cytokine
in response to low dose (1 nM) or high dose (1,000 nM)
peptide. There was no decrease in IFN-
 
 
 
–producing clo-
notypic T cells from CD28WT H-Y pregnants compared
with nonpregnants in response to either dose of antigen, in
contrast to the diminished proliferative and CTL responses
observed in these T cells (Fig. 3, b and d). Unexpectedly,
however, there was a 60% decrease in IFN-
 
 
 
 producing
clonotypic T cells from d18 CD28KO H-Y pregnants
compared with T cells from nonpregnant CD28KO H-Y
females (3.8 
 
 
 
 1.1% vs. 9.6 
 
 
 
 2.3%, P 
 
  
 
0.05) when stim-
ulated with 0.1 nM peptide. Decreased responsiveness was
not overcome using a high dose of antigen, 1,000 nM
(12.1 
 
 
 
 4.2% vs. 29.5 
 
 
 
 5.5%, P 
 
  
 
0.02). This altered IFN- 
response indicates that encounter of the CD28KO T cells
with H-Y antigen during pregnancy has occurred and that
these T cells are not ignorant of the presence of H-Y. The
absence of altered IFN-  production in cells from
CD28WT pregnant females indicates that this is not a non-
specific effect of pregnancy.
Figure 2. CD28 is required for induction of clonal dele-
tion. (a) Decreased recovery of H-Y–specific T cells from
pregnant females (WT nonpregnant, n   28; WT d18, n  
6; WT d18 w/ females, n   3; KO nonpregnant, n   16;
KO d18, n   12) and (b) increase in memory phenotype in
remaining T cells (WT nonpregnant, n   17; WT d18,
n   6; WT d18 females only, n   3; KO nonpregnant,
n   11; KO d18, n   11). Spleen cells from WT or KO
nonpregnant, or d18 pregnants with mixed litters or litters
with only females were analyzed for expression of T3.70
(H-Y–specific TCR) and CD62L by flow cytometry. Re-
sults represent pooled data from multiple experiments.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
23 Vacchio and Hodes
H-Y–specific CTL responses were also compared in
spleen cells from pregnant or nonpregnant CD28WT and
CD28KO H-Y mice. There was approximately a 50% de-
crease in CTL activity observed in T cells from pregnant
CD28WT females compared with that observed from
CD28WT nonpregnant females (Fig. 3 c). However, there
was no alteration in the cytotoxic activity from cells recov-
ered from pregnant CD28KO females compared with
those recovered from CD28KO nonpregnant females. Col-
lectively these data suggest that in the absence of CD28,
pregnancy fails to induce either clonal deletion or hypore-
sponsiveness of H-Y specific CD8 T cells.
To determine whether the defect in CD8 tolerance ob-
served in CD28-deficient mice reflects a requirement for
CD28/B7 interactions, we generated H-Y mice that were
deficient in both B7.1 and B7.2 (B7DKO). B7DKO H-Y
pregnant females did not undergo deletion of clonotypic T
cells when compared with recovery from B7DKO H-Y
nonpregnants (Fig. 4 a), paralleling the absence of deletion
observed in T cells from the CD28KO H-Y pregnants.
Furthermore, there was no alteration in CTL activity (Fig.
4 b) or proliferative responsiveness (unpublished data) of
cells recovered from B7DKO pregnants. Thus, both dele-
tion of clonotypic T cells and the induction of diminished
responsiveness in surviving cells are dependent upon B7 as
well as CD28, consistent with a requirement for CD28/B7
interaction in these pathways of peripheral tolerance.
Discussion
This study has explored for the first time the role of
CD28 in the induction of peripheral tolerance in CD8 T
Figure 3. (a) H-Y–specific T cells recovered from CD28WT d18 pregnants exhibit decrease proliferation to H-Y peptide. 4   105 CFSE-labeled
spleen cells from either nonpregnant or d18 pregnant H-Y CD28WT mice were cultured with 0.1 nM peptide for 72 h. T cells from pregnancies with
mixed litters were compared with pregnancies with only females in the litter. (b) H-Y–specific T cells recovered from CD28KO pregnants do not exhibit
decreased proliferation to H-Y peptide or male APCs. 4   105 CFSE-labeled spleen cells from either nonpregnant or d18 pregnant H-Y CD28WT or
KO mice were cultured with 0.1 nM peptide for 72 h. Proliferation was assessed by dye dilution after gating on T3.70 Annexin V  cells (nonpregnant,
n   28; d18, n   6; d18 females only, n   3; CD28KO nonpregnant, n   16; CD28WT d18, n   12). (c) Fewer H-Y–specific T cells recovered from
CD28KO pregnants secrete IFN- . 4   105 spleen cells from CD28WT or CD28KO H-Y mice were cultured in the presence of 1,000 nM or 1 nM
peptide for 72 h, then harvested and cultured for an additional 6 h in the presence of GolgiStop, 200 ng/ml PMA, and 750 ng/ml ionomycin. Clono-
typic T cells were analyzed for intracellular expression of IFN- . Similar results were obtained in experiments restimulating with peptide instead of PMA
and ionomycin. (d) H-Y–specific T cells from CD28KO d18 pregnants do not exhibit decreased CTL activity. 4   106 CFSE-labeled spleen cells from
CD28WT or CD28KO H-Y mice were cultured with 1  M peptide for 72 h, harvested, and cultured with EL-4 cells in the absence or presence of pep-
tide for 4 h. EL-4 target cells were then analyzed for expression of Annexin V by flow cytometry. Results represent pooled data from multiple experi-
ments (CD28WT nonpregnant, n   9; CD28WT d18, n   3; CD28KO nonpregnant, n   6; CD28KO d18, n   4).T
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cells in vivo. Analyzing proliferation, cytokine secretion,
and CTL generation of MHC class I–restricted T cells
from CD28WT and CD28KO H-Y RAG-2 KO mice,
we have found that CD28 costimulation is dispensible for
in vitro activation. Activation of CD28KO T cells was not
diminished even when using very low concentrations of
peptide antigen, or male APCs that express a low but phys-
iological concentration of antigen. It was therefore surpris-
ing that we found CD28 is required in vivo for both the
induction of clonal deletion and for antigen-specific hypo-
responsiveness of CD8 T cells. These data demonstrate a
previously unanticipated role for CD28 in tolerance induc-
tion of CD8 cells.
We have previously used pregnancy as a model to study
peripheral tolerance in the maternal immune system to the
fetal antigen, H-Y. Tolerance to H-Y expressed by male
fetuses appears to be mediated by a combination of de-
creased survival of H-Y–specific T cells in vivo and de-
creased responsiveness of the remaining T cells as deter-
mined by in vitro challenge with antigen (26). That this is
not a nonspecific effect of pregnancy itself but rather anti-
gen-mediated is confirmed by the lack of deletion or hypo-
responsiveness observed in pregnant females with litters
consisting of only female pups. The reduction in clono-
typic T cells could not be accounted for either by TCR
down-regulation, or by migration to the sites of H-Y anti-
gen expression, either the placenta itself or the draining
lymph nodes of the placenta (our unpublished data).
Therefore, it is likely that the decreased numbers of H-Y
reactive T cells are due to cell death resulting from antigen
encounter whether occurring in lymphoid tissues, or in
nonlymphoid tissues after emigration.
The dependence on CD28 costimulation for induction
of clonal deletion is unexpected. At least for CD4 T cells, it
has been proposed that CD28 costimulation is required for
clonal deletion of T cells to self-antigen because activation
is required for activation-induced cell death to occur (31).
The absence of clonal deletion in CD28KO mice would
therefore be consistent with this model. However, it is im-
portant to consider that while CD4 T cells have a requisite
dependence on CD28 for activation, it appears that the
H-Y–specific CD8 T cells studied here do not. Therefore,
it is in this respect surprising that clonal deletion of these
CD8 cells is CD28 dependent while activation is not.
These results suggest a novel role for CD28 in determining
the fate of CD8 T cells.
H-Y–specific T cells that escape deletion in pregnant
CD28WT females exhibit a form of anergy defined by de-
creased proliferative responses that are not reversed by IL-2
(26). The remaining CD28WT T cells in pregnant mice
exhibit decreased levels of CD62L, confirmation that these
cells have encountered antigen, and also have decreased
CTL activity in response to H-Y antigen. In marked con-
trast, H-Y–specific T cells from pregnant CD28KO mice
did not exhibit either decreased proliferation or decreased
CTL activity, nor did they down-regulate CD62L raising
the possibility that these T cells have not been activated by
antigen. However, T cells from the d18 CD28KO preg-
nants had significantly lower levels of IFN- –producing
cells compared with T cells from the CD28KO nonpreg-
nant females, indicating that these cells are not “antigen ig-
norant” but have seen antigen in vivo and responded, albeit
in an altered manner. The decrease in INF- –producing
cells is a not a nonspecific effect of pregnancy since T cells
from d18 CD28WT pregnants do not exhibit decreased
IFN- –producing cells.
The phenomenon of “split tolerance” observed here in
CD8 cells from pregnant CD28 WT mice, in which unre-
sponsiveness was induced in some but not other parameters
of T cell responses, has previously been reported in other
experimental systems. Diminished proliferative response,
but intact cytokine and/or CTL function, has been ob-
served in vitro (32) as well as in in vivo systems of periph-
eral tolerance (33, 34). However, the means by which this
type of split tolerance occurs is unclear. Interestingly, the
inverse functional pattern is observed in T cells from
CD28KO H-Y pregnants, which have normal CTL activ-
ity and proliferation yet decreased numbers of IFN- –pro-
ducing cells. Future studies will determine whether there
are differences in TCR signaling in T cells from CD28WT
and CD28KO H-Y pregnants that may account for func-
tional differences in these populations, as has previously
Figure 4. B7 is required for induction of peripheral tol-
erance. (a) T cells from B7DKO H-Y pregnant females
were compared with B7DKO H-Y nonpregnant females
for T3.70 expression. (b) H-Y–specific T cells from
B7DKO d18 pregnants do not exhibit decreased CTL ac-
tivity. 4   106 CFSE-labeled spleen cells from B7DKO
H-Y mice were cultured with 1  M peptide for 72 h, har-
vested, and cultured with EL-4 cells in the absence or pres-
ence of peptide for 4 h. EL-4 target cells were then ana-
lyzed for expression of Annexin V by flow cytometry.
Results represent pooled data from multiple experiments.
(B7DKO nonpregnant, n   3; B7DKO d18, n   3).T
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been suggested in circumstances of split tolerance (34).
One question that arises is whether the “split tolerance”
that we as well as others have observed is truly “tolerance”
since there is not a total abrogation of responsiveness in
these systems. In the experimental system characterized
here, the hyporesponsiveness observed by the residual T
cells appears to be sufficient to prevent an immune re-
sponse and rejection of the fetus, and therefore could be ar-
gued to be true functional tolerance.
The role of costimulation in the induction of anergy has
previously been addressed in studies of CD4 T cells, and it
has been proposed that CTLA-4/B7 interactions may be
particularly important in the induction of anergy (14, 17).
It has also been reported that two kinds of anergy can be
induced in vitro, one that is induced by TCR stimulation
in the absence of CD28 and is reversible by IL-2 and the
other that is induced by CTLA-4 signals and is not revers-
ible by IL-2 (35). The antigen-specific hyporesponsiveness
that we have observed in H-Y–specific transgenic CD8 T
cells resembles the second of these anergic states, in that it is
not reversible by IL-2 (26). However, in our model of pe-
ripheral tolerance, anergy induction does not occur in
CD28KO mice, despite the fact that CTLA-4/B7 interac-
tions remain intact in these animals. This finding supports
the observation by Frauwirth et al. that demonstrated
CTLA-4 is not required for induction of in vivo anergy us-
ing CD8 TCR transgenic mice (36), again suggesting dif-
ferent roles for the CD28/CTLA-4/B7 costimulatory
pathway between CD4 and CD8 T cells. The importance
of CD28/B7 interactions in tolerance induction is further
confirmed by the lack of both deletion and anergy induced
in the B7DKO H-Y pregnants.
In conclusion, our data demonstrate that CD8 cells can
respond efficiently to even low concentrations of antigen in
the absence of CD28 costimulation in vitro. However, pe-
ripheral tolerance in vivo does not occur in the absence of
CD28. To our knowledge this is the first in vivo assessment
of the role for CD28 in peripheral tolerance induction of
CD8 cells and the first evidence that CD28 is critical for
tolerance induction of CD8 cells. These findings suggest
that the role of CD28/CTLA-4/B7 interactions in periph-
eral tolerance of CD8 T cells may differ significantly from
that for CD4 T cells and demonstrate that CD28 is in-
volved in both clonal deletion and induction of hypore-
sponsiveness by encounter with peripheral self-antigen.
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